# [Feline Respiratory Infections](/knowledge/bacteria/pet-bacteria/feline-respiratory-infections-causes-transmission-zoonotic-risk): Etiology, Transmission, Clinical Management, and Zoonotic Potential
## Key Takeaways
- Feline respiratory infections are typically polymicrobial, involving synergistic viral agents like feline herpesvirus 1 (FHV-1) and feline calicivirus (FCV), alongside bacterial pathogens such as *Chlamydia felis*, *Bordetella bronchiseptica*, and *Mycoplasma* species.
- Transmission occurs primarily via direct contact with infected cats or through fomites contaminated with respiratory secretions, with aerosolized droplets from sneezing and coughing being a significant route, particularly in high-density environments like shelters.
- Clinical presentation ranges from mild conjunctivitis and rhinitis to severe pneumonia, with characteristic signs including serous to mucopurulent discharge, sneezing, conjunctival hyperemia, and oral ulcerations.
- Diagnosis relies on clinical signs and confirmatory laboratory testing, with multiplex PCR assays being the gold standard for identifying key viral and bacterial agents due to their high sensitivity and specificity.
- Management involves targeted therapy, including antiviral agents like famciclovir for FHV-1, antibiotics such as doxycycline for *C. felis* and *B. bronchiseptica*, and comprehensive supportive care to maintain hydration, nutrition, and airway patency.
- The zoonotic potential is limited but present for *Bordetella bronchiseptica* (causing pertussis-like illness in immunocompromised individuals), *Chlamydia felis* (rarely causing conjunctivitis), and *Pasteurella multocida* (via bites/scratches), necessitating standard hygiene practices.
---
## Introduction
[Feline respiratory infections](/knowledge/bacteria/pet-bacteria/feline-respiratory-infections-causes-transmission-zoonotic-risk) represent a complex of contagious diseases affecting the upper and lower respiratory tracts of domestic cats. These infections are typically polymicrobial, involving both viral and bacterial pathogens that act synergistically to produce clinical disease [1]. The most common etiologic agents include [feline herpesvirus 1](/knowledge/viruses/pet-viruses/feline-herpesvirus-1) (FHV-1), [feline calicivirus](/knowledge/viruses/pet-viruses/feline-calicivirus) (FCV), *Chlamydia felis*, *[Bordetella bronchiseptica](/knowledge/bacteria/pet-bacteria/bordetella-bronchiseptica)*, and *Mycoplasma* species [2]. Secondary bacterial infections frequently exacerbate primary viral damage, leading to more severe clinical outcomes [3]. Understanding the etiology, transmission dynamics, clinical management strategies, and zoonotic potential of these infections is essential for veterinary practitioners, diagnosticians, and public health professionals.
## Etiology
### Viral Agents
FHV-1 is an enveloped, double-stranded DNA virus belonging to the family *Herpesviridae* [1]. The virus exhibits tropism for mucosal epithelial cells of the upper respiratory tract and conjunctiva, causing cytolytic infection with characteristic syncytia formation [2]. Latency is established in trigeminal ganglia, and reactivation occurs during periods of stress or immunosuppression [3].
FCV is a non-enveloped, single-stranded RNA virus of the family *Caliciviridae* [1]. It displays high genetic diversity and mutability, resulting in multiple antigenic strains [2]. The virus replicates in oral and respiratory epithelial cells, causing vesiculation, ulceration, and rhinitis [3].
### Bacterial Agents
Primary bacterial pathogens that cause feline respiratory disease include *Chlamydia felis*, *[Bordetella bronchiseptica](/knowledge/bacteria/pet-bacteria/bordetella-bronchiseptica)*, and *Mycoplasma felis* [2]. *C. felis* is an obligate intracellular Gram-negative bacterium with a biphasic life cycle alternating between infectious elementary bodies and metabolically active reticulate bodies [1]. *B. bronchiseptica* is a small, Gram-negative coccobacillus that expresses adhesins and toxins that impair mucociliary clearance [3]. *M. felis* lacks a cell wall and adheres to respiratory epithelial cells, disrupting ciliary function [2].
Secondary bacterial invaders frequently isolated from complicated cases include *Pasteurella multocida*, *Streptococcus* species, *Staphylococcus* species, and various enteric Gram-negative rods [1]. These organisms are often opportunistic pathogens that take advantage of virus-induced mucosal damage [3].
The following table summarizes key bacterial agents in [feline respiratory infections](/knowledge/bacteria/pet-bacteria/feline-respiratory-infections-etiology-clinical-presentation-diagnostic-approach).
| Pathogen | Gram Status | Morphology | Key Virulence Factors | Primary Site of Infection |
|-----|-------|------|-----------|--------------|
| *Chlamydia felis* | Gram-negative (obligate intracellular) | Elementary/reticulate bodies | Type III secretion system, heat shock proteins | Conjunctiva, nasal mucosa |
| *Bordetella bronchiseptica* | Gram-negative | Coccobacillus | Filamentous hemagglutinin, adenylate cyclase toxin, dermonecrotic toxin | Nasal epithelium, trachea, bronchi |
| *Mycoplasma felis* | No cell wall (Gram stain poorly) | Pleomorphic, small | Adhesins, hydrogen peroxide production | Upper respiratory tract, conjunctiva |
| *Pasteurella multocida* | Gram-negative | Coccoid rod | Capsular polysaccharide, lipopolysaccharide, dermonecrotic toxin | Nasopharynx, lower airways (secondary) |
## How Do Cats Get Respiratory Infections
Transmission of feline respiratory pathogens occurs primarily through direct contact with infected cats or through exposure to fomites contaminated with respiratory secretions [1]. Aerosolized droplets produced during sneezing and coughing can travel short distances (up to 1-2 meters) and deposit on conjunctival or nasal mucosal surfaces [2]. FHV-1 is shed in ocular, nasal, and oral secretions, and transmission can also occur via contaminated litter boxes, food bowls, and bedding [3]. FCV is highly stable in the environment and can persist on dry surfaces for weeks, facilitating indirect transmission [1]. *B. bronchiseptica* is shed in respiratory exudates and can be transmitted through direct nose-to-nose contact or via contaminated water sources [2]. *C. felis* is shed in ocular and nasal discharges and requires close contact for transmission due to its intracellular nature [3].
Stress factors such as overcrowding, poor ventilation, concurrent disease, and recent transportation increase susceptibility to infection and promote shedding of latent FHV-1 [1]. Shelters, boarding facilities, and multi-cat households are high-risk environments for respiratory disease transmission [2].
## Are [Cat Respiratory Infections](/knowledge/bacteria/pet-bacteria/cat-respiratory-infections-etiology-clinical-signs-zoonotic-potential-management) Dangerous
The clinical severity of [feline respiratory infections](/knowledge/bacteria/pet-bacteria/feline-respiratory-infections-etiology-clinical-signs-and-zoonotic-risk) ranges from mild self-limiting conjunctivitis to life-threatening pneumonia, especially in kittens, geriatric cats, and immunocompromised individuals [1]. FHV-1 infection can cause severe ulcerative keratitis, corneal scarring, and symblepharon formation if not managed appropriately [2]. FCV infection may result in oral ulcerations, hypersalivation, and in virulent systemic strains, systemic disease with high mortality [3]. *B. bronchiseptica* is associated with tracheobronchitis and bronchopneumonia, particularly in young kittens [1]. *C. felis* typically causes persistent conjunctivitis and mild rhinitis but can lead to chronic ocular disease without treatment [2].
Secondary bacterial infections significantly worsen prognosis and may lead to chronic rhinosinusitis, aspiration pneumonia, and systemic illness [3]. Mortality rates are low in adult cats with adequate immune function but can exceed 30% in kittens with severe viral-bacterial coinfections managed without intensive care [1].
## Clinical Signs and Diagnostic Approach
Common clinical signs include serous to mucopurulent ocular and nasal discharge, sneezing, conjunctival hyperemia, chemosis, blepharospasm, oral ulceration, pyrexia, lethargy, anorexia, and in severe cases, dyspnea and open-mouth breathing [2]. Chronic cases may present with nasal congestion, stertor, and persistent ocular discharge [3].
Diagnosis is based on clinical presentation, history, and confirmatory laboratory testing. Conjunctival and nasal swabs are collected for pathogen detection. Polymerase chain reaction (PCR) assays are the gold standard for identifying FHV-1, FCV, *C. felis*, *B. bronchiseptica*, and *Mycoplasma* species due to their high sensitivity and specificity [1]. Serology is of limited utility in acute disease due to widespread seroprevalence and vaccine-induced antibodies [2]. Bacterial culture and antimicrobial susceptibility testing should be performed when secondary bacterial infection is suspected or when initial treatment fails [3].
The following Mermaid diagram outlines a diagnostic workflow for [feline respiratory infections](/knowledge/bacteria/pet-bacteria/feline-respiratory-infections-etiology-clinical-signs-and-zoonotic-risk).
```mermaid
graph TD
A["Cat presenting with respiratory signs"] --> B{"Clinical history and physical exam"}
B --> C["Ocular/nasal discharge, sneezing, conjunctivitis, oral ulcers"]
C --> D["Collect conjunctival and nasal swabs"]
D --> E["Perform multiplex PCR for FHV-1, FCV, C. felis, B. bronchiseptica, Mycoplasma spp."]
E --> F{"Positive for primary pathogen?"}
F -->|"Yes"| G["Treat specific pathogen: antivirals for FHV-1, supportive for FCV, antibiotics for bacteria"]
F -->|"No"| H{"Secondary bacterial infection suspected?"}
H -->|"Yes"| I["Bacterial culture and antimicrobial susceptibility from nasal swab or bronchoalveolar lavage"]
H -->|"No"| J["Consider non-infectious causes: allergy, foreign body, neoplasia"]
I --> K["Targeted antibiotic therapy based on sensitivity"]
K --> L["Re-evaluate clinical response in 7,10 days"]
G --> L
L --> M{"Clinical improvement?"}
M -->|"Yes"| N["Continue treatment and monitor"]
M -->|"No"| O["Repeat diagnostic testing, consider advanced imaging"]
O --> P["CT or rhinoscopy to evaluate for chronic rhinosinusitis"]
```
## Clinical Management
Treatment strategies are directed at the identified etiologic agents and supportive care to maintain hydration and nutritional status. Antiviral therapy for FHV-1 includes famciclovir, a prodrug that inhibits viral DNA polymerase, administered at 40-90 mg/kg orally three times daily [1]. Topical cidofovir or idoxuridine ophthalmic drops are used for herpetic keratitis [2]. No specific antiviral is approved for FCV; management relies on supportive care, including fluid therapy, nutritional support, and analgesia for oral ulcers [3].
Antibiotic therapy is indicated for bacterial pathogens. *C. felis* responds to tetracyclines; doxycycline at 5 mg/kg orally twice daily for 14 days is the first-line choice [1]. *B. bronchiseptica* is susceptible to tetracyclines and fluoroquinolones; doxycycline or marbofloxacin are commonly used [2]. *Mycoplasma* species are inherently resistant to beta-lactams due to the absence of a cell wall; macrolides, tetracyclines, or fluoroquinolones are effective [3]. Secondary bacterial infections may require broad-spectrum antibiotics such as amoxicillin-clavulanate or a combination of a beta-lactam with a fluoroquinolone until culture results guide definitive therapy [1].
Supportive measures include humidification to soothe inflamed airways, nebulization with saline or mucolytics, nutritional supplementation via appetite stimulants or feeding tubes, and oxygen therapy for hypoxemic patients [2]. In chronic cases, surgical intervention such as nasal flushing, turbinectomy, or frontal sinus trephination may be indicated to remove inspissated exudate and necrotic debris [3].
## [Is Cat Respiratory Infection Contagious to Humans](/knowledge/bacteria/pet-bacteria/feline-upper-respiratory-infection-zoonotic-potential)
The zoonotic potential of [feline respiratory infections](/knowledge/bacteria/pet-bacteria/feline-respiratory-infections-etiology-clinical-signs-zoonotic-risk-prevention) is limited but exists for certain pathogens. *B. bronchiseptica* is a primary pathogen of dogs, cats, and pigs but can cause respiratory disease in immunocompromised humans, particularly those with underlying pulmonary conditions or congenital immunodeficiency [1]. Human infection typically manifests as a pertussis-like illness with paroxysmal cough, though cases of bronchitis and pneumonia have been reported [2]. Transmission occurs via direct contact with infected cat respiratory secretions or fomites [3].
*C. felis* is considered a rare zoonotic pathogen. Ocular infections in humans, primarily conjunctivitis, have been documented in individuals handling infected cats without appropriate hygiene [1]. The risk is highest among veterinary personnel and shelter workers [2]. *Pasteurella multocida*, although a secondary invader in feline respiratory disease, is a well-recognized zoonotic agent transmitted through bites, scratches, or direct mucous membrane contact, causing local wound infections, cellulitis, and rarely, respiratory infection in humans [3].
FHV-1 and FCV are not known to cause disease in humans [1]. *Mycoplasma felis* has occasionally been implicated in human conjunctivitis or respiratory tract colonization but is not considered a significant zoonotic threat [2]. Standard hygiene practices, including hand washing after handling cats and use of gloves when cleaning ocular/nasal discharges, are effective in preventing zoonotic transmission [3].
## Conclusion
[Feline respiratory infections](/knowledge/bacteria/pet-bacteria/feline-respiratory-infections-etiology-clinical-signs-zoonotic-risk-prevention) are multifactorial diseases involving primary viral and bacterial pathogens acting in concert with secondary invaders. Transmission occurs through direct and indirect contact, with stress and high-density housing amplifying spread. Disease severity ranges from mild to life-threatening, particularly in vulnerable populations. Accurate diagnosis using molecular methods allows targeted therapy, which may include antivirals, antibiotics, and intensive supportive care. [Zoonotic risk](/knowledge/parasites/pet-parasites/zoonotic-risk-humans-get-parasites-from-pets) is low but clinically relevant for *B. bronchiseptica*, *C. felis*, and *P. multocida*, emphasizing the importance of infection control measures in veterinary settings.
## References
[1] Greene, C. E. (ed.). Infectious Diseases of the Dog and Cat. 4th ed. Saunders Elsevier. (Standard veterinary reference text.)
[2] Sykes, J. E. Canine and Feline Infectious Diseases. Elsevier. (Standard veterinary reference text.)
[3] Chandler, E. A., Gaskell, C. J., & Gaskell, R. M. Feline Medicine and Therapeutics. 3rd ed. Blackwell Publishing. (Standard veterinary reference text.)
## Related Clinical & Scientific Guides
* [Duck Diseases: A Comprehensive Overview for Veterinary Practitioners](/knowledge/bacteria/general/duck-diseases-comprehensive-overview-veterinary)
* [Salmonella Dublin in Cattle: Emerging Pathogen, Diagnostic Challenges, and Public Health Impact](/knowledge/bacteria/general/salmonella-dublin-cattle-emerging-pathogen-diagnostic-public-health)
* [Mycoplasma Infections in Poultry: Vaccination Strategies and Control Programs](/knowledge/bacteria/general/mycoplasma-infections-in-poultry-vaccination-strategies-and-control-programs)